Prism Medico & Pharmacy Ltd Hits New 52-Week High at Rs.24.88

Strong Rally and Price Momentum

On 24 Feb 2026, Prism Medico & Pharmacy Ltd opened with a notable gap up of 4.98%, immediately setting the tone for the day’s trading. The stock maintained this elevated level throughout the session, touching an intraday high of Rs.24.88, which also stands as the new 52-week high. This price represents a substantial appreciation from its 52-week low of Rs.11.62, underscoring a remarkable recovery and growth trajectory over the past year.

The stock has recorded a consecutive gain streak spanning six trading days, during which it has delivered an impressive 46.78% return. This sustained upward movement has propelled Prism Medico well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling strong technical momentum and investor confidence in the stock’s current trend.

Outperformance Relative to Sector and Market

Prism Medico & Pharmacy Ltd’s performance has notably outpaced its Non Banking Financial Company (NBFC) sector peers. On the day of the new high, the stock outperformed the sector by 5.49%, highlighting its relative strength amid broader market fluctuations. This is particularly significant given the wider market context, where the Sensex experienced a decline of 510.81 points, or 0.9%, closing at 82,541.73. The benchmark index remains 4.38% shy of its own 52-week high of 86,159.02, indicating that Prism Medico’s rally is not merely a reflection of general market trends but driven by company-specific factors.

Financial and Market Metrics

Despite the positive price action, Prism Medico & Pharmacy Ltd holds a Mojo Score of 46.0 with a current Mojo Grade of Sell, downgraded from Hold as of 17 Nov 2025. The company’s market cap grade stands at 4, reflecting its micro-cap status within the NBFC sector. These metrics provide a comprehensive view of the stock’s valuation and risk profile, balancing the recent price gains with underlying fundamental assessments.

Year-on-Year Performance Comparison

Over the past 12 months, Prism Medico & Pharmacy Ltd has delivered a total return of 50.61%, significantly outperforming the Sensex’s 10.90% gain over the same period. This outperformance highlights the stock’s resilience and ability to generate value beyond broader market movements. The stock’s rise from Rs.11.62 to Rs.24.88 within a year reflects a doubling in price, a noteworthy achievement for a micro-cap NBFC.

Technical Indicators and Trading Range

The stock’s trading behaviour today was characterised by a stable price range, opening and maintaining the Rs.24.88 level without significant intraday volatility. This stability at the new high suggests strong demand and limited selling pressure at this price point. The alignment of the stock price above all major moving averages further confirms the bullish technical setup, which has been building over recent weeks.

Sector Context and Market Environment

While Prism Medico & Pharmacy Ltd has surged, the NBFC sector as a whole has experienced mixed performance, with the broader Sensex index retreating amid a negative opening and sustained selling pressure. The Sensex’s position below its 50-day moving average, despite the 50DMA trading above the 200DMA, indicates a cautious market environment. Against this backdrop, Prism Medico’s ability to chart a new 52-week high is particularly notable.

Summary of Key Metrics

To summarise, Prism Medico & Pharmacy Ltd’s stock price has reached Rs.24.88, its highest level in 52 weeks, following a six-day consecutive gain period with a cumulative return of 46.78%. The stock’s outperformance relative to its NBFC sector peers and the broader Sensex index underscores its strong momentum. Despite a Mojo Grade downgrade to Sell, the stock’s technical indicators remain robust, trading above all major moving averages and maintaining a stable price range at the new high.

This milestone reflects a significant achievement for Prism Medico & Pharmacy Ltd, highlighting its capacity to generate substantial returns within a challenging market environment.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →